Hyperbolic mixed-type inhibition of acetylcholinesterase by tetracyclic thienopyrimidines

References

• Soreq H, Seidman S. Acetylcholinesterase–new roles for an old actor. Nat Rev Neurosci 2001; 2:294–302.
   PubMed Web of Science ®Google Scholar
• Silman I, Sussman JL. Acetylcholinesterase: ‘classical’ and ‘non-classical’ functions and pharmacology. Curr Opin Pharmacol 2005; 5:293–302.
   PubMed Web of Science ®Google Scholar
• Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 1991; 253:872–879.
   PubMed Web of Science ®Google Scholar
• Colletier JP, Fournier D, Greenblatt HM, Stojan J, Sussman JL, Zaccai G, Silman I, Weik M. Structural insights into substrate traffic and inhibition in acetylcholinesterase. EMBO J 2006; 25:2746–2756.
   PubMed Web of Science ®Google Scholar
• Johnson G, Moore SW. The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design. Curr Pharm Des 2006; 12:217–225.
   PubMed Web of Science ®Google Scholar
• Inestrosa NC, Dinamarca MC, Alvarez A. Amyloid-cholinesterase interactions. Implications for Alzheimer’s disease. FEBS J 2008; 275:625–632.
   PubMed Web of Science ®Google Scholar
• Giacobini E, Becker RE. One hundred years after the discovery of Alzheimer’s disease. A turning point for therapy? J Alzheimers Dis 2007; 12:37–52.
   PubMed Web of Science ®Google Scholar
• Melnikova I. Therapies for Alzheimer’s disease. Nat Rev Drug Discov 2007;6:341–342.
   PubMed Web of Science ®Google Scholar
• Muñoz-Torrero D, Camps P. Dimeric and hybrid anti-Alzheimer drug candidates. Curr Med Chem 2006; 13:399–422.
   PubMed Web of Science ®Google Scholar
• Musial A, Bajda M, Malawska B. Recent developments in cholinesterases inhibitors for Alzheimer’s disease treatment. Curr Med Chem 2007; 14:2654–2679.
   PubMed Web of Science ®Google Scholar
• Muñoz-Torrero D. Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer’s disease. Curr Med Chem 2008; 15:2433–2455.
   PubMed Web of Science ®Google Scholar
• Lin G, Liu YC, Lin YF, Wu YG. Ortho effects in quantitative structure-activity relationships for acetylcholinesterase inhibition by aryl carbamates. J Enzyme Inhib Med Chem 2004; 19:395–401.
   PubMed Web of Science ®Google Scholar
• Marco-Contelles J, León R, de Los Ríos C, Guglietta A, Terencio J, López MG, García AG, Villarroya M. Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer’s disease. J Med Chem 2006; 49:7607–7610.
   PubMed Web of Science ®Google Scholar
• Elsinghorst PW, Tanarro CM, Gütschow M. Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase. J Med Chem 2006; 49:7540–7544.
   PubMed Web of Science ®Google Scholar
• Tumiatti V, Minarini A, Bolognesi ML, Milelli A, Rosini M, Melchiorre C. Tacrine derivatives and Alzheimer’s disease. Curr Med Chem 2010;17:1825–1838.
   PubMed Web of Science ®Google Scholar
• Elsinghorst PW, Cieslik JS, Mohr K, Tränkle C, Gütschow M. First gallamine-tacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor. J Med Chem 2007;50:5685–5695.
   PubMed Web of Science ®Google Scholar
• Elsinghorst PW, Härtig W, Goldhammer S, Grosche J, Gütschow M. A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques. Org Biomol Chem 2009;7:3940–3946.
   PubMed Web of Science ®Google Scholar
• Härtig W, Kacza J, Paulke BR, Grosche J, Bauer U, Hoffmann A, Elsinghorst PW, Gütschow M. In vivo labelling of hippocampal beta-amyloid in triple-transgenic mice with a fluorescent acetylcholinesterase inhibitor released from nanoparticles. Eur J Neurosci 2010; 31:99–109.
   PubMed Web of Science ®Google Scholar
• Pietsch M, Gütschow M. Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition. J Med Chem 2005; 48:8270–8288.
   PubMed Web of Science ®Google Scholar
• Kryger G, Silman I, Sussman JL. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Struct Fold Des 1999;7:297–307.
   Google Scholar
• Piazzi L, Rampa A, Bisi A, Gobbi S, Belluti F, Cavalli A, Bartolini M, Andrisano V, Valenti P, Recanatini M. 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer’s disease therapy. J Med Chem 2003; 46:2279–2282.
   PubMed Web of Science ®Google Scholar
• Pietsch M, Christian L, Inhester T, Petzold S, Gütschow M. Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile. FEBS J 2009; 276:2292–2307.
   PubMed Web of Science ®Google Scholar
• Ram VJ, Pandey HK, Vlietinck AJ. Thieno[2,3-d]pyrimidines as potential chemotherapeutic agents. II. J. J Heterocyclic Chem 1981;18:1277–1280.
   Web of Science ®Google Scholar
• Smolanka IV, Khripak SM, Frolova NP. Dobosh AA. Alkylation of 2-thioureido-3-carboxythiophenes. Ukr Khim Zh 1979;45:871–872.
   Google Scholar
• Leistner S, Gütschow M, Wagner G. The facile synthesis of 2-aminothieno[2,3-d][1,3]thiazin-4-ones, in some cases 5,6-anellated. Synthesis 1987;466–470.
   Google Scholar
• Leistner S, Wagner G, Gütschow M, Glusa E. Synthesis of 7-benzyl-5,6,7,8-tetrahydro-pyrido[4′,3′:4,5]thieno [2,3-d]pyrimidine-4(3H)-ones with alkylthioester groups in position 2 and examination of their platelet aggregation-inhibiting activity. Pharmazie 1986; 41:54–55.
   PubMed Web of Science ®Google Scholar
• Leistner S, Gütschow M, Vieweg H, Wagner G, Strohscheidt T, Grupe R. Various synthetic routes to imidazo[1,2-c]thieno[3,2-e]pyrimidines and pyrimido[1,2-c]thieno[3,2-e]pyrimidines in some cases anellated. Pharmazie 1988; 43:756–760.
   Google Scholar
• Ghorab MM. New biologically active N-(tetrahydrobenzothieno-pyrimidin-4-yl)-amino acids, thiourethane, sulfonamides and related compounds. Phosphorus Sulfur Silicon Relat Elem 2000;165:221–35.
   Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Huang Y, Dömling A. The Gewald multicomponent reaction. Mol Divers 2010 (DOI: 10.1007/s11030-010-9229-6).
   Google Scholar
• Leistner S, Gütschow M, Wagner G. A facile synthesis of 2-alkylthio-4-amino-thieno[2,3-d]pyrimidines. Arch Pharm (Weinheim) 1989;322:227–30.
   Web of Science ®Google Scholar
• Segel IH. Enzyme kinetics. Behavior and analysis of rapid equilibrium and steady-state enzyme systems. New York: John Wiley & Sons Inc., 1993:161–226.
   Google Scholar
• Baici A. The specific velocity plot. A graphical method for determining inhibition parameters for both linear and hyperbolic enzyme inhibitors. Eur J Biochem 1981; 119:9–14.
   PubMedGoogle Scholar
• Nochi S, Asakawa N, Sato T. Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020). Biol Pharm Bull 1995; 18:1145–1147.
   PubMed Web of Science ®Google Scholar